Clinical Trial Update: Stalevo in Early Wearing-Off Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Stalevo in patients with idiopathic Parkinson's disease experiencing early wearing-off.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Parkinson Disease

Drugs mentioned

• Stalevo (levodopa;carbidopa;entacapone)

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Idiopathic Parkinson's Disease | Phase 4 | Status: COMPLETED